siRNA, Anti-Human LAPTM4A, LNA(CAT#: SIRGT34251WQ-LNA)

The product SIRGT34251WQ-LNA is a type of small interfering RNA (siRNA) that targets LAPTM4A gene and regulates the expression of gene. The siRNA interferes with the expression of LAPTM4A gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
Modification Locked Nucleic Acid (LNA)
Scale 20/50/100/200 nmole
NCBI RefSeq NM_014713.4
Alternative Names HUMORF13; LAPTM4; MBNT; Mtrp
Related Diseases Shoulder Impingement Syndrome, Myofascial Pain Syndrome
Purification HPLC
Target Gene
Gene ID 9741
Uniprot ID Q15012

Related Products